Eps Summary of Synmosa Biopharma Corporation

Synmosa Biopharma Corporation's latest annual eps in 2023 was 1.46 TWD , down -28.44% from previous year.
Synmosa Biopharma Corporation's latest quarterly eps in 2024 Q2 was 0.48 TWD , down 0.0% from previous quarter.
Synmosa Biopharma Corporation reported an annual eps of 2.25 TWD in 2022, up 167.86% from previous year.
Synmosa Biopharma Corporation reported an annual eps of 0.84 TWD in 2021, down -57.79% from previous year.
Synmosa Biopharma Corporation reported a quarterly eps of 0.48 TWD for 2024 Q1, up 6.67% from previous quarter.
Synmosa Biopharma Corporation reported a quarterly eps of 0.45 TWD for 2023 Q4, up 28.57% from previous quarter.

Annual Eps Chart of Synmosa Biopharma Corporation (2023 - 2019)

Name	Eps	Eps Difference
Allied Biotech Corporation	1.01 TWD	-44.554%
GeneFerm Biotechnology Co., Ltd.	3.01 TWD	51.495%
Easywell Biomedicals, Inc.	-1.25 TWD	216.8%
TTY Biopharm Company Limited	4.54 TWD	67.841%
Orient EuroPharma Co., Ltd.	1.66 TWD	12.048%
Center Laboratories, Inc.	-1.50 TWD	197.333%
Tien Liang BioTech Co., Ltd.	0.39 TWD	-274.359%
Orient Pharma Co., Ltd.	0.10 TWD	-1360.0%
InnoPharmax Inc.	-0.76 TWD	292.105%
Johnson Chemical Pharmaceutical Works Co., Ltd.	2.24 TWD	34.821%
Excelsior Biopharma Inc.	-1.94 TWD	175.258%
DV Biomed Co., Ltd.	7.89 TWD	81.496%
Foresee Pharmaceuticals Co., Ltd.	-8.14 TWD	117.936%
Handa Pharmaceuticals, Inc.	5.41 TWD	73.013%
UniPharma Co., Ltd.	-0.61 TWD	339.344%
Anxo Pharmaceutical Co., Ltd.	0.42 TWD	-247.619%
Alar Pharmaceuticals Inc.	6.71 TWD	78.241%
Winston Medical Supply Co., Ltd.	8.58 TWD	82.984%
Mercury Biopharmaceutical Corporation	-0.11 TWD	1427.273%
Bioray Biotech Co., Ltd	-0.38 TWD	484.211%
TSH Biopharm Corporation Limited	1.61 TWD	9.317%